Tag Archives: NERV

free online stock trading

Crocs (NASDAQ:CROX)’s share price reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $17.86 and last traded at $17.73, with a volume of 30192 shares changing hands. The stock had previously closed at $17.44.

Several equities analysts have recently commented on CROX shares. Piper Jaffray Companies set a $18.00 target price on Crocs and gave the....More>>>

Best Dividend Stocks To Buy For 2019

With the S&P 500 yielding less than 2%, dividend investors wanting more than that paltry payout can look to individual stocks for better yields. All dividend stocks aren’t created equal, though, so investors should be picky. A high yield often comes with risks, and the last thing any dividend investor wants is for a dividend cut to both slash their income and drive down the value of a....More>>>

Top 5 Stocks To Watch Right Now

Wedding season in the U.S. is not what it used to be, and bridal retailers are feeling the pain.

In the latest sign of industry stress, executives at David’s Bridal Inc. have hired restructuring advisers at Evercore Inc. and legal counsel at Debevoise & Plimpton to help turn around the budget-priced business, according to people with knowledge of the situation. The chain also appointed....More>>>

Top 5 Blue Chip Stocks To Watch Right Now

Wall Street on Monday didn’t just cash in on one winner, or a daily double, or even a trifecta. It notched astock market-style superfecta, with all four major U.S. stock indexes — representing blue chip names, technology stocks, small caps and large-company stocks — all closing at record highs on the same day for the first time in 17years.

The post-election rallybegan two....More>>>

Top Performing Stocks To Invest In 2019

Source: ThinkstockJanuary 10, 2018: The S&P 500 closed down 0.1% at 2,748.18. The DJIA closed down less than 0.1% at 25,370.55. Separately, the Nasdaq was down 0.1% at 7,153.57.

Wednesday was a down day for the U.S. markets. The markets initially opened down, but over the course of the day they slowly moved back towards even. Earnings season is just around the corner, and starting Friday....More>>>

Hot Value Stocks To Buy For 2019

Warren Buffett. Image source: The Motley Fool.

Since the beginning of 2016, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has seen the value of the seven bank stocks in its investment portfolio increase by $5.6 billion, or 10.8%.

That’s a lot of money, butwhen you compare it to how blue-chip bank stocks performed more generally, something interesting sticks out. While Berkshire’s....More>>>

Top Performing Stocks To Buy For 2018

Source: ThinkstockFebruary 23, 2018: The S&P 500 closed up 1.6% at 2,747.47. The DJIA closed up 1.4% at 25,311.92. Separately, the Nasdaq was up 1.8% at 7,337.39.

Friday was a very positive day for the broadU.S. markets, with all three of the major exchanges closing higher on the day. Crude oil made a strong recovery and is back above $63. The S&P 500 sectors were entirely positive.....More>>>

Top 10 High Tech Stocks To Watch Right Now

A few months ago, I published five warning signs for the end of the "Melt Up" for paid subscribers to my True Wealth Systems letter…   At the time, NONE of them were worth worrying about… The five indicators were "all clear."   But today, at least one of them is not.   I will share this indicator with you today. And I'll tell you what it means....More>>>

stock graphs

The Q4 2016 earnings report for mid cap dairy and organics stock WhiteWave Foods Co (NYSE: WWAV) is scheduledfor before the market opens onThursday (February 16th). WhiteWave Foods was in our SmallCap Network Elite Opportunity (SCN EO) portfolio back in October 2014 with our SCN EO newsletter having this to say at the time:

When you break down WWAV’s fundamentals, there’s no question....More>>>

stock marker

As concerns about Gilead Sciences (GILD) mount, Maxim’s Jason Kolbert are bullish on the biotech giant’s HIV franchise but not enough to change his Hold rating on the stock:

Associated Press

We recently spoke with GILD management about the launch of Genvoya and other HIV products. Our model now factors in our forecast for patient switch trends from other Gilead products....More>>>